Form 4 for CRL Charles River Laboratories
Accepted 2026-06-03 21:45:20 ET · period of report 2026-06-02 · accession 0001100682-26-000103 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-03 21:45 | 2026-06-02 | CRL | Barg Steven | Dir | A - Grant | $174.79 | +422 | 3,287 | +15% | +$73.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-02 | A | A | 422 | $174.79 | 3,287 | D | — | — | (F1) The grant was made in lieu of director service fees for the term commencing May 5, 2026. The restricted stock units vest upon the earlier of 6/2/2027, or the business day prior to the Company's next annual meeting of shareholders. |